Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3114 results found
Expand All
Apply All
3114 results found

Good Day BIO: Tell the government how it can support biotech
Share
Good Day BIO Newsletter  •  December 20, 2022
The government wants you to weigh in on how to streamline biotech regulation and the value of the bioeconomy—we tell you how. Plus, BIO’s been working with international partners on global regulatory harmonization of pharmaceutical regulations, which could help us prepare for the next pandemic. (613 words, 3 minutes, 3 seconds)
Read More

What's in the government funding package
Share
Good Day BIO Newsletter  •  December 20, 2022
BIO experts have been analyzing the 4,155-page omnibus spending bill since it was delivered around 2 a.m. yesterday. There are key provisions related to biopharma, agriculture, and environment. (805 words, 4 minutes, 1 second)
Read More

Good Day BIO: Mexico proposes amendments to corn ban
Share
Good Day BIO Newsletter  •  December 19, 2022
We’re officially in the home stretch of the year. Today, we have news on Mexico’s proposed corn ban, a recap of BIO’s event during the U.S.-Africa Summit and what it means for cancer in Africa, and a lot more health news. (791 words, 3 minutes, 57 seconds)
Read More

Good Day BIO: Midterms recap and Mexico's corn ban
Share
Good Day BIO Newsletter  •  December 16, 2022
For your weekend reading, we have our 2022 midterms recap: what happened, why it matters, and what the results mean for biotech innovation and patients. Plus, ahead of Agriculture Secretary Vilsack’s meeting with Mexico today, bipartisan Senators are calling for the U.S. to take action on the proposed corn ban. (740 words, 3 minutes, 42 seconds)
Read More

Good Day BIO: FDA cut back on Accelerated Approvals in 2022
Share
Good Day BIO Newsletter  •  December 15, 2022
With appropriations negotiations underway on Capitol Hill, we look at what some members of Congress want the package to say about genome editing for food. Plus,the FDA cut back on use of Accelerated Approval in 2022—a very unwelcome holiday surprise for patients.  (634 words, 3 minutes, 10 seconds)
Read More

Good Day BIO: COVID vaccines at two years
Share
Good Day BIO Newsletter  •  December 14, 2022
Hard to believe the first COVID vaccines were administered in the U.S. two years ago today—here’s more on the impact on lives and money saved, and future R&D. Plus, President Biden’s hosting the U.S.-Africa Leaders Summit and today will highlight the role for biotech. (501 words, 2 minutes, 30 seconds)
Read More

BIO Comments on FDA Discussion Paper: Distributed Manufacturing and Point-of-Care Manufacturing of Drugs
Share
Letters, Testimony & Comments  •  December 13, 2022
On Tuesday, December 13th, BIO submitted comments in response to a recent FDA discussion paper for stakeholders on distributed manufacturing (DM) and point-of-care (POC) manufacturing. In the comments submitted, BIO commended the FDA on its collaborative approach to addressing unique challenges related to advanced manufacturing and noted that discussion paper provides a timely mechanism to further the harmonization of terminology and concepts around DM and POC. Along with specific feedback on the questions raised by the Agency in the paper, BIO offered several high-level recommendations. For example, it would be beneficial if FDA more clearly conveyed the benefits offered by DM and POC manufacturing while acknowledging the relative risks associated with their introduction. Furthermore, it would be useful if the document recognized and addressed the limitations that manufacturers face in attempting to deploy these technologies in different regions and settings.
Read More

Good Day BIO: Inequities persist in R&D
Share
Good Day BIO Newsletter  •  December 13, 2022
Recent data provides more evidence of the need for equity and inclusion in clinical trials and drug development—here’s what we’re doing about it. And while we know the lame duck is busy, the Senate should add two key agriculture nominations to the agenda. (551 words, 2 minutes, 45 seconds)
Read More

Optimize your time and investment by downloading a networking info app for the 41st Annual JP Morgan Health Care Conference
Share
Press Release  •  December 12, 2022
VANCOUVER, BC, CANADA, and WASHINGTON, DC, UNITED STATES, Dec. 12, 2022 – Today, Novateur Ventures, a leading global life sciences advisory firm and Biotechnology Innovation Organization (BIO), the world's largest advocacy association for biosciences, research and academic institutions, launched an industry networking information app, Event Guide to JPM 2023, which provides listings for an anticipated >200 satellite networking events taking place during the 41st Annual J.P. Morgan Health Care Conference on January 9-12, 2023, in San Francisco, CA. The Event Guide to JPM 2023 app, developed by Novateur Ventures and co-managed by BIO, features event search and filter capabilities, provides links to event and registration information, and in the case of in-person events, loads mapping software for directions to the event. Organizations can also use the app to list their scheduled events being held during the conference timeframe. "It was important for me to develop an app that allowed life science professionals to make important industry connections because, over my career, some of the most transformational relationships I have developed are the direct result of industry networking events. Novateur is delighted to be collaborating with BIO, to give the app a global reach," says Ali Ardakani, Founder and Managing Director of Novateur Ventures. “I see the app as a natural addition to BIO Partnering at JPM Week. We’re always working to help the industry partner more easily and effectively, and I’m excited to bring the whole JPM Week networking landscape to the palm of your hand. We are excited to be partnering with Novateur on managing and launching this app,” says Mackensie Vernetti, BIO’s Director of Partnering Operations. About Novateur VenturesNovateur Ventures is an established life sciences advisory and investment firm with extensive experience in business development and product development of therapeutics, medical devices, and digital health products. For more…
Read More

Good Day BIO: Antibiotic resistance on the rise
Share
Good Day BIO Newsletter  •  December 12, 2022
A new WHO report highlights how common bacteria are growing more resistant to antibiotics—but you can take action this week. Plus, bipartisan House Ways & Means Committee members are calling for USTR to open a dispute settlement with Mexico. (650 words, 3 minutes, 15 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 115
  • 116
  • 117
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO